TY  - JOUR
AU  - Radojević-Škodrić, Sanja
AU  - Basta-Jovanović, Gordana
AU  - Brašanac, Dimitrije
AU  - Nikolić, Nadja
AU  - Bogdanović, Ljiljana
AU  - Miličić, Biljana
AU  - Milašin, Jelena
PY  - 2012
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1744
AB  - Survivin, an apoptotic inhibitor, is overexpressed in various types of cancer. Mechanisms of survivin upregulation are still poorly understood, but single nucleotide polymorphisms in the survivin gene promoter have been shown to modulate survivin expression and consequently the risk for some types of cancer. The aim of the present study was to investigate whether survivin promoter -31 G/C and -241 C/T polymorphisms could represent susceptibility factors for Wilms tumor (WT) development in Serbian population. Genotype and allele frequencies for the 2 polymorphisms in survivin promoter have been analyzed by polymerase chain reaction/restriction fragment length polymorphism in 59 WT patients and 82 controls. The frequencies of alleles and genotypes were significantly different between patients and controls for the -31 G/C polymorphism. Individuals with CC and CG genotypes had significantly decreased risk of WT compared with GG individuals (odds ratio 0.26, 95% confidence interval, 0.07-0.96; odds ratio 0.30, 95% confidence interval, 0.15-0.60). There was also a statistically significant difference in genotype frequencies between intermediate and high-risk prognostic groups (P = 0.015). The -241 C/T polymorphism did not show association with WT susceptibility. Our findings suggest that the G allele at -31 survivin gene promoter position is associated with a significantly higher cancer risk in Serbian children, with a gene dosage effect.
PB  - Lippincott Williams & Wilkins, Philadelphia
T2  - Journal of Pediatric Hematology Oncology
T1  - Survivin Gene Promoter -31 G/C Polymorphism Is Associated With Wilms Tumor Susceptibility in Serbian Children
VL  - 34
IS  - 8
SP  - E310
EP  - E314
DO  - 10.1097/MPH.0b013e31825d3076
ER  - 

@article{
author = "Radojević-Škodrić, Sanja and Basta-Jovanović, Gordana and Brašanac, Dimitrije and Nikolić, Nadja and Bogdanović, Ljiljana and Miličić, Biljana and Milašin, Jelena",
year = "2012",
abstract = "Survivin, an apoptotic inhibitor, is overexpressed in various types of cancer. Mechanisms of survivin upregulation are still poorly understood, but single nucleotide polymorphisms in the survivin gene promoter have been shown to modulate survivin expression and consequently the risk for some types of cancer. The aim of the present study was to investigate whether survivin promoter -31 G/C and -241 C/T polymorphisms could represent susceptibility factors for Wilms tumor (WT) development in Serbian population. Genotype and allele frequencies for the 2 polymorphisms in survivin promoter have been analyzed by polymerase chain reaction/restriction fragment length polymorphism in 59 WT patients and 82 controls. The frequencies of alleles and genotypes were significantly different between patients and controls for the -31 G/C polymorphism. Individuals with CC and CG genotypes had significantly decreased risk of WT compared with GG individuals (odds ratio 0.26, 95% confidence interval, 0.07-0.96; odds ratio 0.30, 95% confidence interval, 0.15-0.60). There was also a statistically significant difference in genotype frequencies between intermediate and high-risk prognostic groups (P = 0.015). The -241 C/T polymorphism did not show association with WT susceptibility. Our findings suggest that the G allele at -31 survivin gene promoter position is associated with a significantly higher cancer risk in Serbian children, with a gene dosage effect.",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Journal of Pediatric Hematology Oncology",
title = "Survivin Gene Promoter -31 G/C Polymorphism Is Associated With Wilms Tumor Susceptibility in Serbian Children",
volume = "34",
number = "8",
pages = "E310-E314",
doi = "10.1097/MPH.0b013e31825d3076"
}

Radojević-Škodrić, S., Basta-Jovanović, G., Brašanac, D., Nikolić, N., Bogdanović, L., Miličić, B.,& Milašin, J.. (2012). Survivin Gene Promoter -31 G/C Polymorphism Is Associated With Wilms Tumor Susceptibility in Serbian Children. in Journal of Pediatric Hematology Oncology
Lippincott Williams & Wilkins, Philadelphia., 34(8), E310-E314.
https://doi.org/10.1097/MPH.0b013e31825d3076

Radojević-Škodrić S, Basta-Jovanović G, Brašanac D, Nikolić N, Bogdanović L, Miličić B, Milašin J. Survivin Gene Promoter -31 G/C Polymorphism Is Associated With Wilms Tumor Susceptibility in Serbian Children. in Journal of Pediatric Hematology Oncology. 2012;34(8):E310-E314.
doi:10.1097/MPH.0b013e31825d3076 .

Radojević-Škodrić, Sanja, Basta-Jovanović, Gordana, Brašanac, Dimitrije, Nikolić, Nadja, Bogdanović, Ljiljana, Miličić, Biljana, Milašin, Jelena, "Survivin Gene Promoter -31 G/C Polymorphism Is Associated With Wilms Tumor Susceptibility in Serbian Children" in Journal of Pediatric Hematology Oncology, 34, no. 8 (2012):E310-E314,
https://doi.org/10.1097/MPH.0b013e31825d3076 . .

TY  - JOUR
AU  - Basta-Jovanović, Gordana
AU  - Radojević-Škodrić, Sanja
AU  - Brašanac, Dimitrije
AU  - Đuricić, S.
AU  - Milašin, Jelena
AU  - Bogdanović, L.
AU  - Oprić, D.
AU  - Savin, M.
AU  - Baralić, I.
AU  - Jovanović, M.
PY  - 2012
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1747
AB  - Purpose: To determine survivin expression patterns in Wilms tumor (WT) and compare it with the expression in normal renal tissue. Also, to analyse cytoplasmic and nuclear survivin expression in relation to histological type, prognostic group and tumor stage. Methods: Immunohistochemical expression of survivin was analysed in 59 cases of primary WT and in 10 normal kidney specimens, taken from the same patients, but distant from the tumor. Results: 51 out of 59 cases of WT (86.44%) showed decreased cytoplasmic survivin expression and 4 out of 59 cases of WT (6.78%) showed nuclear overexpression of survivin. There was statistically significant difference in the frequency of decreased cytoplasmic expression of survivin in individual components of WT (p=0.005). Decreased cytoplasmic expression of survivin in epithelial, blastemal and stromal component was found significantly more often in low stage WT compared to high stage WT (Fisher exact test, p=0.0002, p=0.002, p=0.002, respectively). There was no statistically significant difference in the frequency of survivin nuclear overexpression between different stages of WT (Fisher exact test, p=0.564), histological types (Fisher exact test, p=0.915), or between different prognostic groups (Fisher exact test, p=1). Conclusion: Decreased survivin cytoplasmic expression or nuclear overexpression may be related to favorable prognosis of WT.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Prognostic value of survivin expression in Wilms tumor
VL  - 17
IS  - 1
SP  - 168
EP  - 173
UR  - https://hdl.handle.net/21.15107/rcub_smile_1747
ER  - 

@article{
author = "Basta-Jovanović, Gordana and Radojević-Škodrić, Sanja and Brašanac, Dimitrije and Đuricić, S. and Milašin, Jelena and Bogdanović, L. and Oprić, D. and Savin, M. and Baralić, I. and Jovanović, M.",
year = "2012",
abstract = "Purpose: To determine survivin expression patterns in Wilms tumor (WT) and compare it with the expression in normal renal tissue. Also, to analyse cytoplasmic and nuclear survivin expression in relation to histological type, prognostic group and tumor stage. Methods: Immunohistochemical expression of survivin was analysed in 59 cases of primary WT and in 10 normal kidney specimens, taken from the same patients, but distant from the tumor. Results: 51 out of 59 cases of WT (86.44%) showed decreased cytoplasmic survivin expression and 4 out of 59 cases of WT (6.78%) showed nuclear overexpression of survivin. There was statistically significant difference in the frequency of decreased cytoplasmic expression of survivin in individual components of WT (p=0.005). Decreased cytoplasmic expression of survivin in epithelial, blastemal and stromal component was found significantly more often in low stage WT compared to high stage WT (Fisher exact test, p=0.0002, p=0.002, p=0.002, respectively). There was no statistically significant difference in the frequency of survivin nuclear overexpression between different stages of WT (Fisher exact test, p=0.564), histological types (Fisher exact test, p=0.915), or between different prognostic groups (Fisher exact test, p=1). Conclusion: Decreased survivin cytoplasmic expression or nuclear overexpression may be related to favorable prognosis of WT.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Prognostic value of survivin expression in Wilms tumor",
volume = "17",
number = "1",
pages = "168-173",
url = "https://hdl.handle.net/21.15107/rcub_smile_1747"
}

Basta-Jovanović, G., Radojević-Škodrić, S., Brašanac, D., Đuricić, S., Milašin, J., Bogdanović, L., Oprić, D., Savin, M., Baralić, I.,& Jovanović, M.. (2012). Prognostic value of survivin expression in Wilms tumor. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 17(1), 168-173.
https://hdl.handle.net/21.15107/rcub_smile_1747

Basta-Jovanović G, Radojević-Škodrić S, Brašanac D, Đuricić S, Milašin J, Bogdanović L, Oprić D, Savin M, Baralić I, Jovanović M. Prognostic value of survivin expression in Wilms tumor. in Journal of BUON. 2012;17(1):168-173.
https://hdl.handle.net/21.15107/rcub_smile_1747 .

Basta-Jovanović, Gordana, Radojević-Škodrić, Sanja, Brašanac, Dimitrije, Đuricić, S., Milašin, Jelena, Bogdanović, L., Oprić, D., Savin, M., Baralić, I., Jovanović, M., "Prognostic value of survivin expression in Wilms tumor" in Journal of BUON, 17, no. 1 (2012):168-173,
https://hdl.handle.net/21.15107/rcub_smile_1747 .

TY  - JOUR
AU  - Basta-Jovanović, Gordana
AU  - Gvozdenović, E.
AU  - Dimitrijević, I.
AU  - Brašanac, Dimitrije
AU  - Vučković, Mila
AU  - Kalezić, Nevena
AU  - Baralić, I.
AU  - Radojević-Škodrić, Sanja
AU  - Arsić, D.
PY  - 2008
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1395
AB  - The aim of our study was to investigate the expression of γ-catenin in normal kidney and in Wilms' tumor by immunohistochemistry and to correlate the results with tumor stage, histological type, and prognostic group. We investigated 28 cases of Wilms' tumor, 2 Wilms' tumor metastases in lungs, and 1 specimen of normal renal tissue. Expression of γ-catenin was detected in 14 cases. There was a weak inverse relationship between γ-catenin expression and tumor stage. Expression of γ-catenin was detected in various histologic types of Wilms' tumor, but there was no statistically significant correlation, except in cases with diffuse anaplasia that were negative. In 2 metastatic cases and in the case of bilateral Wilms' tumor γ-catenin immunostaining was not observed Our findings suggest an absence of strong correlation between the loss of γ-catenin and unfavorable outcome.
T2  - Fetal & Pediatric Pathology
T1  - Immunohistochemical analysis of gamma catenin in Wilms' tumors
VL  - 27
IS  - 2
SP  - 63
EP  - 70
DO  - 10.1080/15513810802028704
ER  - 

@article{
author = "Basta-Jovanović, Gordana and Gvozdenović, E. and Dimitrijević, I. and Brašanac, Dimitrije and Vučković, Mila and Kalezić, Nevena and Baralić, I. and Radojević-Škodrić, Sanja and Arsić, D.",
year = "2008",
abstract = "The aim of our study was to investigate the expression of γ-catenin in normal kidney and in Wilms' tumor by immunohistochemistry and to correlate the results with tumor stage, histological type, and prognostic group. We investigated 28 cases of Wilms' tumor, 2 Wilms' tumor metastases in lungs, and 1 specimen of normal renal tissue. Expression of γ-catenin was detected in 14 cases. There was a weak inverse relationship between γ-catenin expression and tumor stage. Expression of γ-catenin was detected in various histologic types of Wilms' tumor, but there was no statistically significant correlation, except in cases with diffuse anaplasia that were negative. In 2 metastatic cases and in the case of bilateral Wilms' tumor γ-catenin immunostaining was not observed Our findings suggest an absence of strong correlation between the loss of γ-catenin and unfavorable outcome.",
journal = "Fetal & Pediatric Pathology",
title = "Immunohistochemical analysis of gamma catenin in Wilms' tumors",
volume = "27",
number = "2",
pages = "63-70",
doi = "10.1080/15513810802028704"
}

Basta-Jovanović, G., Gvozdenović, E., Dimitrijević, I., Brašanac, D., Vučković, M., Kalezić, N., Baralić, I., Radojević-Škodrić, S.,& Arsić, D.. (2008). Immunohistochemical analysis of gamma catenin in Wilms' tumors. in Fetal & Pediatric Pathology, 27(2), 63-70.
https://doi.org/10.1080/15513810802028704

Basta-Jovanović G, Gvozdenović E, Dimitrijević I, Brašanac D, Vučković M, Kalezić N, Baralić I, Radojević-Škodrić S, Arsić D. Immunohistochemical analysis of gamma catenin in Wilms' tumors. in Fetal & Pediatric Pathology. 2008;27(2):63-70.
doi:10.1080/15513810802028704 .

Basta-Jovanović, Gordana, Gvozdenović, E., Dimitrijević, I., Brašanac, Dimitrije, Vučković, Mila, Kalezić, Nevena, Baralić, I., Radojević-Škodrić, Sanja, Arsić, D., "Immunohistochemical analysis of gamma catenin in Wilms' tumors" in Fetal & Pediatric Pathology, 27, no. 2 (2008):63-70,
https://doi.org/10.1080/15513810802028704 . .

TY  - JOUR
AU  - Radojević-Škodrić, Sanja
AU  - Đuricić, S.
AU  - Vučković, Mila
AU  - Dimitrijević, I.
AU  - Lazić, Miodrag
AU  - Stojšić, Z.
AU  - Brašanac, Dimitrije
AU  - Basta-Jovanović, Gordana
PY  - 2007
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1375
AB  - Abnormalities in cell cycle regulators and subsequent deregulation of G1-S transition may be one of the most important biological events in the malignant transformation of cells. The aim of this study was to investigate the expression of Cyclin E in the normal kidney, and in Wilms tumor, and to correlate the results with tumor stage, histological type and prognostic group. We have investigated 28 cases of Wilms tumor, two Wilms tumor metastases in lungs and one case of normal renal tissue. Correlation of semiquantitatively scored cyclin E levels with histopathological parameters was performed for all cases. Diffuse expression of cyclin E was more frequent in the blastemal (without epithelial component) then in the epithelial (without blastemal) component. This correlation showed high significance (p=0.001). Diffuse expression of cyclin E was more frequent in stage III/IV/V (71.4%) than in stage I/II (42.9%), showing no significant correlation (p>0.05). The intermediate risk group of Wilms tumor showed more frequent cyclin E diffuse expression (66.7%) in comparison with high risk cases (20%), showing statistical significance (p lt 0.05). Our findings suggest that diffuse expression of cyclin E is associated with the prognostic group and tumor stage. Also, cyclin E expression is more pronounced in the blastemal component than in the epithelial component.
PB  - Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd
T2  - Acta Veterinaria
T1  - Immunohistochemical analysis of cyclin E in Wilms tumors
VL  - 57
IS  - 5-6
SP  - 453
EP  - 464
DO  - 10.2298/AVB0706453R
ER  - 

@article{
author = "Radojević-Škodrić, Sanja and Đuricić, S. and Vučković, Mila and Dimitrijević, I. and Lazić, Miodrag and Stojšić, Z. and Brašanac, Dimitrije and Basta-Jovanović, Gordana",
year = "2007",
abstract = "Abnormalities in cell cycle regulators and subsequent deregulation of G1-S transition may be one of the most important biological events in the malignant transformation of cells. The aim of this study was to investigate the expression of Cyclin E in the normal kidney, and in Wilms tumor, and to correlate the results with tumor stage, histological type and prognostic group. We have investigated 28 cases of Wilms tumor, two Wilms tumor metastases in lungs and one case of normal renal tissue. Correlation of semiquantitatively scored cyclin E levels with histopathological parameters was performed for all cases. Diffuse expression of cyclin E was more frequent in the blastemal (without epithelial component) then in the epithelial (without blastemal) component. This correlation showed high significance (p=0.001). Diffuse expression of cyclin E was more frequent in stage III/IV/V (71.4%) than in stage I/II (42.9%), showing no significant correlation (p>0.05). The intermediate risk group of Wilms tumor showed more frequent cyclin E diffuse expression (66.7%) in comparison with high risk cases (20%), showing statistical significance (p lt 0.05). Our findings suggest that diffuse expression of cyclin E is associated with the prognostic group and tumor stage. Also, cyclin E expression is more pronounced in the blastemal component than in the epithelial component.",
publisher = "Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd",
journal = "Acta Veterinaria",
title = "Immunohistochemical analysis of cyclin E in Wilms tumors",
volume = "57",
number = "5-6",
pages = "453-464",
doi = "10.2298/AVB0706453R"
}

Radojević-Škodrić, S., Đuricić, S., Vučković, M., Dimitrijević, I., Lazić, M., Stojšić, Z., Brašanac, D.,& Basta-Jovanović, G.. (2007). Immunohistochemical analysis of cyclin E in Wilms tumors. in Acta Veterinaria
Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd., 57(5-6), 453-464.
https://doi.org/10.2298/AVB0706453R

Radojević-Škodrić S, Đuricić S, Vučković M, Dimitrijević I, Lazić M, Stojšić Z, Brašanac D, Basta-Jovanović G. Immunohistochemical analysis of cyclin E in Wilms tumors. in Acta Veterinaria. 2007;57(5-6):453-464.
doi:10.2298/AVB0706453R .

Radojević-Škodrić, Sanja, Đuricić, S., Vučković, Mila, Dimitrijević, I., Lazić, Miodrag, Stojšić, Z., Brašanac, Dimitrije, Basta-Jovanović, Gordana, "Immunohistochemical analysis of cyclin E in Wilms tumors" in Acta Veterinaria, 57, no. 5-6 (2007):453-464,
https://doi.org/10.2298/AVB0706453R . .